Pearl Cohen Zedek Latzer Baratz LLP
Compounds for treatment of cancer
The present invention relates to pharmaceutical compositions for treating cancer comprising BRAF inhibitors, (e.g. vemurafenib) and/or MEK inhibitor, (e.g. trametinib, RO5068760), in combination with anti-tubulin compounds of the invention or other known tubulin inhibitors, and using such compositions for treating cancer such as melanoma, drug-resistant cancer, and cancer metastasis.
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
A A A A A A A A A A A A A A A
A61K A61P A61K A61P A61P A61K A61K A61K A61K A61K A61K A61K A61P A61K A61P
additional inventional inventional inventional inventional additional inventional inventional inventional additional additional inventional inventional inventional inventional
Jianjun Duane D. Jin Wei
Chen Miller Wang Li